| 價格 | ¥343 | ¥493 | ¥726 |
| 包裝 | 50mg | 100mg | 200mg |
| 最小起訂量 | 50mg |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-05-08 |
| 中文名稱:疊氮胸苷 | 英文名稱:Zidovudine |
| CAS:30516-87-1 | 品牌: TargetMol |
| 產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 純度規(guī)格: 99.96% | 產(chǎn)品類別: 抑制劑 |
| 貨號: T022|T1416 |
| 名稱 | Zidovudine |
| 描述 | Zidovudine (ZDV) is a synthetic dideoxynucleoside. After intracellular phosphorylation to its active metabolite, zidovudine inhibits DNA polymerase, resulting in the inhibition of DNA replication and cell death. This agent also decreases levels of available pyrimidines. |
| 細(xì)胞實(shí)驗(yàn) | Zidovudine is prepared in DMSO (10 mM) and stored, and then diluted with appropriate medium before use[1]. Assays are performed in all cell types in the presence of titrating concentrations of ARV. 5,000 SVG, 2,500 PFA, 200,000 PBMC, or 50,000 MDM cells/well are seeded into triplicate wells of 96-well plates. Twenty-four hours later, the culture medium is removed and replaced with medium containing the ARV or DMSO (0.5% vol/vol), and equivalent TCID50 infectious units of luciferase reporter virus are added to the cells. After a 16 h incubation at 37°C, the initial viral inoculum is removed and replaced with culture medium containing the same antiretroviral drug (ARV) or DMSO (0.5% vol/vol) concentrations. At 72 h post infection, the medium is aspirated, the cells are lysed and HIV-1 infection measured using the Luciferase Assay System. Luminescence is measured using a FLUOStar Optima microplate reader. Inhibition curves and the 50% (EC50) and 90% (EC90) effective concentrations are determined by nonlinear regression analysis, using GraphPad Prism software[1]. |
| 體內(nèi)活性 | Intravitrous injection of the NRTIs Lamivudine (3TC), Zidovudine (AZT), or Abacavir (ABC) suppresses the laser-induced choroidal neovascularization (CNV) in wild-type mice compared to PBS vehicle. The mean level of VEGF-A in the RPE/choroid, which peaks on day 3 after laser injury, is significantly reduced in 3TC-, AZT- and ABC-treated eyes compared with control eyes in wild-type mice, but not inP2rx7-/- mice[6]. |
| 存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | H2O : 13.4 mg/mL (50.14 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (7.48 mM), Sonication is recommended. DMSO : 242.5 mg/mL (907.42 mM), Sonication is recommended. |
| 關(guān)鍵字 | Zidovudine | Telomerase reverse transcriptase | ReverseTranscriptase | Reverse Transcriptase | NSC-602670 | NSC602670 | Inhibitor | inhibit | Human immunodeficiency virus | HIVProtease | HIV Protease | HIV | CRISPR/Cas9 | CRISPR | Cas9 |
| 相關(guān)產(chǎn)品 | Valproic Acid | (-)-Epigallocatechin Gallate | Emtricitabine | Dextran sulfate sodium salt (MW 5000) | Lamivudine | 5-Fluorouracil | Decanedioic acid | Bromhexine hydrochloride | Chloroquine | Stavudine | Indole-2-carboxylic acid | Dimethyl fumarate |
| 相關(guān)庫 | 抑制劑庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | EMA 上市藥物庫 | 抗衰老化合物庫 | 苦味化合物庫 | FDA 上市藥物庫 | 抗病毒庫 | 免疫/炎癥分子化合物庫 | 藥物功能重定位化合物庫 | 兒童藥物庫 | 毒性化合物庫 |
| 成立日期 | 2013-04-18 (14年) | 注冊資本 | 566.2651萬人民幣 |
| 員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 化學(xué)試劑,生物活性小分子 | 經(jīng)營模式 | 貿(mào)易,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報(bào)價日期 | |
|---|---|---|---|---|
| 詢價 |
VIP2年
|
湖北源夢生物科技有限公司
|
2026-07-29 | |
| 詢價 |
VIP13年
|
四川省維克奇生物科技有限公司
|
2026-07-29 | |
| 詢價 |
VIP8年
|
成都彼樣生物科技有限公司
|
2026-07-29 | |
| ¥1200 |
VIP5年
|
上海雅吉生物科技有限公司
|
2026-07-29 | |
| 詢價 |
VIP10年
|
武漢維斯?fàn)柭锕こ逃邢薰?/div>
|
2026-07-29 | |
| ¥4550 |
VIP5年
|
湖北威德利化學(xué)試劑有限公司
|
2026-07-29 | |
| ¥5500 |
VIP10年
|
湖北威德利化學(xué)試劑有限公司
|
2026-07-29 | |
| 詢價 |
中國食品藥品檢定研究院
|
2026-07-28 | ||
| ¥4500 |
VIP6年
|
武漢維斯?fàn)柭锕こ逃邢薰?/div>
|
2026-07-28 | |
| ¥568 |
VIP5年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2026-07-27 |